Novabay Pharma sees IPO of 5 mln shares at $4-$6 each

Fri Aug 10, 2007 2:01pm EDT

Aug 10 (Reuters) - Novabay Pharmaceuticals Inc. on Friday filed for an initial public offering of 5 million shares at an estimated price of $4 to $6 per share.

The biopharmaceutical company said Dundee Securities Inc. and Blackmont Capital Corp., among others, are underwriting the IPO, according to a filing with the U.S. Securities and Exchange Commission.

The Emeryville, California-based company said it applied for an American Stock Exchange listing under the symbol "NBY." (Reporting by Sayantani Ghosh in Bangalore)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.